Valuation (14%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.03 | 35.38 |
| PEG Ratio (TTM) | 0.00 | 2.31 |
| P/S Ratio (TTM) | N/A | 3.95 |
| P/B Ratio (TTM) | 0.03 | 7.25 |
| P/FCF Ratio (TTM) | N/A | 22.79 |
| Price to 5YR AVG Earnings Ratio | N/A | 35.95 |
| Price to 5YR AVG FCF Ratio | N/A | 27.63 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -11.59% | 6.42% |
| ROE (TTM) | -71.72% | 21.85% |
| Net Profit Margin (TTM) | -47.60% | 10.67% |
| ROIC 5YR AVG | N/A | 19.80% |
Growth (10%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -91.08% | N/A | N/A |
| Revenue | 1.91% | N/A | N/A |
| Net Income | -91.16% | N/A | N/A |
| Cash Flow | 3,087.47% | N/A | N/A |
Health (12%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.35 | 1.72 |
| Quick Ratio (TTM) | 0.35 | 1.71 |
| D/E Ratio (TTM) | 6.08 | 1.08 |
| Interest Coverage (TTM) | -0.28 | 31.16 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | N/A | 5.34 |
| LTL to 5YR AVG FCF | N/A | 3.74 |
| Shares Outstanding Growth 5YR AVG | N/A | 2.30% |